Ophthalmic Med Tech. Firm Sees 166% Gain in LAL Implants
Source: Streetwise Reports  (5/6/22)
Shares of RxSight Inc. traded 7% higher after the company reported Q1/22 financial results which highlighted a 157% YoY increase in revenue and a 208% increase in unit sales of its Light Delivery Devices (LDDâ„¢s) utilized in cataract surgery procedures to implant its RxSight Light Adjustable Lens® (LAL), which it says is "the world's first and only adjustable intraocular lens (IOL) that is customized after cataract surgery." More >

Mining Co. Poised to Win Legal Case Over Zinc Project
  (5/5/22)
The final ruling on the Aznalcollar project, from the Spanish Criminal Court, is expected this year, noted a Clarus Securities report. More >

Analyst Says Avivagen Is a Strong Buy
Source: Clive Maund  (5/5/22)
With Avivagen's breakthrough product relishing in its success, Analyst Clive Maund reviews if he believes it is now a formidable contender as a Buy. More >

Biopharma Co. Licenses Orphan Drug to UK Firm for $450M
Source: Streetwise Reports  (5/5/22)
Intercept Pharmaceuticals Inc. shares traded 20% higher after the company reported it entered into a $450 million licensing agreement with Advanz Pharma in markets outside of the U.S. for Ocaliva® for use in treatment of primary biliary cholangitis, a progressive and chronic autoimmune disease which affects the liver. More >

Lithium Co. Boosts FY22 Adj. EBITDA Outlook
Source: Streetwise Reports  (5/4/22)
Shares of Livent Corp. traded 23% higher after the company reported a 56% YoY increase in Q1/22 revenue driven by strong demand and higher prices and significantly increased its FY/22 adjusted EBITDA forecast. More >

This Copper Explorer Is Readying Its Drills
Source: Streetwise Reports  (5/3/22)
Copper prices have more than doubled since early 2020 as demand continues to outstrip supply. One junior explorer has changed its tack to drill off brownfield exploration targets in an existing copper camp as part of a strategy to get these assets to production in time to capitalize on the forecast highs in copper prices. More >

Exploration Cos. 'Doing Fine' Despite Secular Bear
Source: Michael J. Ballanger  (5/3/22)
Michael J. Ballanger reviews the current market and tells you how to not only make it through, but also rise above the "secular bear." More >

Advanced Chemicals Co. Posts 23% YOY Increase in Net Sales
Source: Streetwise Reports  (5/3/22)
Shares of Chemours Co. traded 16% higher after the company reported Q1/22 financial results and raised its FY/22 adjusted EBITDA estimates by 12% over previous guidance. More >

Pilot Launch of VLN Cigarettes in Progress
  (5/3/22)
These "very low nicotine" tobacco products will be an alternative for smokers when the FDA effects its imminent menthol cigarette ban, noted a ROTH Capital Partners report. More >

Amid Skyrocketing Lithium Price, Geophysical Testing Expands Potential of Argentina Project
Source: Streetwise Reports  (5/2/22)
The explorer, which completed its geophysical surveys at the Rincon West lithium project, will use the data to target drilling. More >

Ecuador Agreement Gives Green Tech Co. Big Tax Break
Source: Streetwise Reports  (5/2/22)
Trading is halted when the Ecuadorian government jumps the gun on announcing an Investment Protection Agreement. More >

FDA Expands Use for Transcarotid Stent
Source: Streetwise Reports  (5/2/22)
Silk Road Medical Inc. shares traded 12% higher after the company reported that the U.S. FDA granted expanded authorization for its ENROUTE® transcarotid stent system for use in preventing stroke in patients deemed to be at standard risk for adverse events from carotid endarterectomy. More >

Biotech Co. Advances COVID-19 Vaccines Toward Approval
  (5/1/22)
They include booster vaccines for different age groups of children and an Omicron-targeting booster for adults, noted an H.C. Wainwright & Co. report. More >

Junior Raising CA$3M; Strategic Investment By Crescat Capital
Source: The Critical Investor  (5/1/22)
The Critical Investor catches up with the CEO of this gold explorer and discusses its latest financing and plans. More >

Aussie Anti-Drone Co. Expected to Turn Cash Flow Positive Soon
Source: Darren Odell  (5/1/22)
A research report from Peloton Capital says this anti-drone company is having a "transformative year" in 2022.
More >

Is Reliq Health Technologies a Nutrimental 'Buy'?
Source: Clive Maund  (4/29/22)
After recovering from a short "character assassination," Reliq Health Technologies may be on the up-and-up. Clive Maund examines the latest data from the company to see if it would make a good 'buy'. More >

Industrial Paper Co. Raises Prices to Offset Inflation
Source: Streetwise Reports  (4/29/22)
Clearwater Paper Corp. shares traded 22.5% higher after the company reported Q1/22 financial results that included a 15% increase in YoY net sales. The firm said it sees continued strength in its paperboard business along with improvements in its parent roll tissue business and has been able to command higher prices to offset higher raw materials and transportation costs. More >

Analyst: Red Metal Stock Set to Grow
Source: Streetwise Reports  (4/28/22)
This junior mining explorer hopes drilling will confirm the high-grade copper it has found in fieldwork at its project in British Columbia. More >

Goldshore Resources Creating a New Asset in Ontario
Source: Maurice Jackson  (4/28/22)
The Moss Lake Property, located in Ontario, has a historical resource. The Moss Lake Property offers year-round exploration in a highly prospective area in Ontario with significant upside resource potential. More >

Is DroneShield LTD. Going to Fly High?
Source: Clive Maund  (4/28/22)
Does Australian-born DroneShield Ltd. show promise for stockholders? Clive Maund reviews the newest updates with the company. More >

Software Co. Posts Strong Organic ARR Growth in Q2
Source: Streetwise Reports  (4/28/22)
PTC Inc. shares traded 18% higher after the software and services firm reported Q2/22 earnings and raised its FY/22 estimates for ARR, revenue and free cash flow. More >

Could a New Prescription Drug Treat This Common Ailment?
  (4/27/22)
The combination drug Halo-Lido is poised to be the first-of-its-kind prescription treatment approved by the U.S. Food and Drug Administration for this prevalent medical condition, noted a DawsonJames report. More >

Copper Find Makes Silver Explorer a 'Buy'
Source: Clive Maund  (4/27/22)
In this article Clive Maund takes a long view of this Canadian silver explorer, flashing back to three years ago to review its trajectory. More >

Silver Junior Hits More High-Grade Veins
Source: Streetwise Reports  (4/27/22)
Peru is home to some of the world's most prolific silver mines. One small-scale silver producer in a past-producing district is cleaning up its balance sheet and drilling off further resources—all while looking at M&A opportunities. It's all part of the plan to achieve long-term growth. More >

Biopharma Co. Posts 32% YoY Gain in Proprietary Sales
Source: Streetwise Reports  (4/27/22)
Alkermes Plc. shares traded 12% higher after the Ireland-based company reported Q1/22 financial results and reiterated its FY/22 business outlook. More >